Diagnostic Value of a Chimeric TSH Receptor (Mc4)-Based Bioassay for Graves’ Disease
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Graves’ disease (GD) is caused by thyroid-stimulating hormone receptor (TSHR) and thyroid-stimulating immunoglobulin (TSI). We used a recently introduced, technically enhanced TSI bioassay to assess its diagnostic value and determine the cut-off in patients in high iodine intake area. Methods: In a cross-sectional setting, we collected serum from 67 patients with untreated GD, 130 with GD under treatment, 22 with GD in remission, 42 with Hashimoto’s thyroiditis, 12 with subacute thyroiditis, 20 with postpartum thyroiditis, and 93 euthyroid controls. TSI was measured using the Thyretain^(TM) bioassay, which is based on Chinese hamster ovary cells transfected with chimeric TSHR (Mc4). TSI levels are reported as a specimen-to-reference ratio percentage (SRR%). Results: The TSI levels in patients with GD (either treated or not) were significantly higher than those of the remaining patients (p < 0.05). The new bioassay showed a sensitivity of 97.0% and a specificity of 95.9% with a cut-off value of 123.0 SRR% for GD. A weak correlation was found between TSI and thyrotropin-binding inhibiting immunoglobulin (TBII) (r_s = 0.259, p = 0.03), but no correlation was found between TSI and tri-iodothyronine or free thyroxine. Conclusions: The Mc4-CHO bioassay showed comparable diagnostic value for GD with the conventional TBII assay. We propose a cut-off of 123.0 SRR% in areas where iodine intake is high.
Abstract
Background/Aims: Graves’ disease (GD) is caused by thyroid-stimulating hormone receptor (TSHR) and thyroid-stimulating immunoglobulin (TSI). We used a recently introduced, technically enhanced TSI bioassay to assess its diagnostic value and determine the cut-off in patients in high iodine intake area. Methods: In a cross-sectional setting, we collected serum from 67 patients with untreated GD, 130 with GD under treatment, 22 with GD in remission, 42 with Hashimoto’s thyroiditis, 12 with subacute thyroiditis, 20 with postpartum thyroiditis, and 93 euthyroid controls. TSI was measured using the Thyretain^(TM) bioassay, which is based on Chinese hamster ovary cells transfected with chimeric TSHR (Mc4). TSI levels are reported as a specimen-to-reference ratio percentage (SRR%). Results: The TSI levels in patients with GD (either treated or not) were significantly higher than those of the remaining patients (p < 0.05). The new bioassay showed a sensitivity of 97.0% and a specificity of 95.9% with a cut-off value of 123.0 SRR% for GD. A weak correlation was found between TSI and thyrotropin-binding inhibiting immunoglobulin (TBII) (r_s = 0.259, p = 0.03), but no correlation was found between TSI and tri-iodothyronine or free thyroxine. Conclusions: The Mc4-CHO bioassay showed comparable diagnostic value for GD with the conventional TBII assay. We propose a cut-off of 123.0 SRR% in areas where iodine intake is high.
참고문헌 (19)
- Brent GA, "Clinical practice: Graves’ disease", N Engl J Med, 358, pp.2594~2605 (2008)
- Ajjan RA, "Techniques to quantify TSH receptor antibodies", Nat Clin Pract Endocrinol Metab, 4, pp.461~468 (2008)
- Smith BR, "A new assay for thyrotropin receptor autoantibodies", Thyroid, 14, pp.830~835 (2004)
- Villalta D, "Analytical and diagnostic accuracy of “second generation” assays for thyrotrophin receptor antibodies with radioactive and chemiluminescent tracers", J Clin Pathol, 57, pp.378~382 (2004)
- Ochi Y, "Augmentative effect of polyethylene glycol, polyvinyl alcohol and dextran on thyroid-stimulating antibody stimulated cAMP production in FRTL-5 cells and CHO cells expressing human TSH receptor", Horm Res, 53, pp.20~25 (2000)
- Preissner CM, "Comparison of thyrotropin-receptor antibodies measured by four commercially available methods with a bioassay that uses Fisher rat thyroid cells", Clin Chem, 49, pp.1402~1404 (2003)
- Hovens GC, "bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves’ disease", Clin Endocrinol (Oxf), 64, pp.429~435 (2006)
- Tahara K, "Immunoglobulins from Graves’ disease patients interact with different sites on TSH receptor", LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients, 1991, pp.179, 70~77
- Lytton SD, "A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves’ orbitopathy", J Clin Endocrinol Metab, 95, pp.2123~2131 (2010)
- Kamijo K, "A novel bioreporter assay for thyrotropin receptor antibodies using a chimeric thyrotropin receptor (mc4) is more useful in differentiation of Graves’ disease from painless thyroiditis than conventional thyrotropin-stimulating antibody assay using porcine thyroid cells", Thyroid, 20, pp.851~856 (2010)
- Rakover Y, "A case of transient hypothyroidism: sequential serum measurements of autoantibodies inhibiting thyrotropin-stimulated thyroid cAMP production in a neonate", Acta Endocrinol (Copenh), 123, pp.118~122 (1990)
- Ueda Y, "Thyroid-stimulating antibodies in sera from patients with Graves’ disease are heterogeneous in epitope recognition", Eur J Endocrinol, 132, pp.62~68 (1995)
- Kim WB, "Clinical significance of classification of Graves’ disease according to the characteristics of TSH receptor antibodies", Korean J Intern Med, 16, pp.187~200 (2001)
- Watson PF, "A new chemiluminescent assay for the rapid detection of thyroid stimulating antibodies in Graves’ disease", Clin Endocrinol (Oxf), 49, pp.577~581 (1998)
- Evans C, "Development of a luminescent bioassay for thyroid stimulating antibodies", J Clin Endocrinol Metab, 84, pp.374~377 (1999)
- Grasso YZ, "Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves’ patients as detected with wild-type versus chimeric thyrotropin receptors", Thyroid, 9, pp.531~537 (1999)
- Kim JY, "Dietary iodine intake and urinary iodine excretion in patients with thyroid diseases", Yonsei Med J, 41, pp.22~28 (2000)
- Kim JY, "Dietary iodine intake and urinary iodine excretion in normal Korean adults", Yonsei Med J, 39, pp.355~362 (1998)
- Flynn A, "Intake of selected nutrients from foods, from fortification and from supplements in various European countries", Food Nutr Res, 53 (2009)